Please login to the form below

Not currently logged in

US drug prices

This page shows the latest US drug prices news and features for those working in and with pharma, biotech and healthcare.

US start-up EQRx promises approach that will slash drug prices

US start-up EQRx promises approach that will slash drug prices

Plans to have its first drug on the market in just five years. ... A new US start-up says it has a plan to completely revamp the approach to drug development, allowing to launch drugs more quickly and at a lower cost.

Latest news

More from news
Approximately 12 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • The Golden Goose The Golden Goose

    Why it’s so hard for the US to curb runaway drug prices. ... Something that is seldom mentioned in the drug pricing debate: the US has a greater number of generics sold at cheaper prices than any other country in the world, with 90%

  • The Orkambi blame game The Orkambi blame game

    The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just ... were ‘freeloading’ while high US prices provide the incentive

  • Deal Watch October 2018

    US drug prices. In other news from the US, there are now expectations of a legislative stalemate following the mid‐term elections in early November. ... It is worth remembering that there are still a few areas where both political parties are prepared

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Trump had tweeted days before that Pfizer “should be ashamed that they have raised drug prices for no reason”, claiming they were “taking advantage of the poor and others unable to ... The Trump administration has also just floated the idea of

  • Deal Watch January 2017 Deal Watch January 2017

    bear on US drug prices and the possible revocation of Obamacare in part, if not in full.  In addition, early press coverage suggests that there may be an introduction of a ... 230. Cymabay. Kowa. Exclusive licence in the US. Arhalofenate for gout p3

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...